Interaction between arsenic exposure from drinking water and genetic susceptibility in carotid intima–media thickness in Bangladesh (original) (raw)

Abstract

Epidemiologic studies that evaluated genetic susceptibility for the effects of arsenic exposure from drinking water on subclinical atherosclerosis are limited. We conducted a cross-sectional study of 1078 participants randomly selected from the Health Effects of Arsenic Longitudinal Study in Bangladesh to evaluate whether the association between arsenic exposure and carotid artery intima-media thickness (cIMT) differs by 207 single-nucleotide polymorphisms (SNPs) in 18 genes related to arsenic metabolism, oxidative stress, inflammation, and endothelial dysfunction. Although not statistically significant after correcting for multiple testing, nine SNPs in APOE, AS3MT, PNP, and TNF genes had a nominally statistically significant interaction with well-water arsenic in cIMT. For instance, the joint presence of a higher level of well-water arsenic (≥40.4 μg/L) and the GG genotype of AS3MT rs3740392 was associated with a difference of 40.9 μm (95% CI = 14.4, 67.5) in cIMT, much greater than the difference of cIMT associated with the genotype alone (β = −5.1 μm, 95% CI = −31.6, 21.3) or arsenic exposure alone (β = 7.2 μm, 95% CI = −3.1, 17.5). The pattern and magnitude of the interactions were similar when urinary arsenic was used as the exposure variable. Additionally, the at-risk genotypes of the AS3MT SNPs were positively related to the proportion of monomethylarsonic acid (MMA) in urine, which is indicative of arsenic methylation capacity. The findings provide novel evidence that genetic variants related to arsenic metabolism may play an important role in arsenic-induced subclinical atherosclerosis. Future replication studies in diverse populations are needed to confirm the findings.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (69)

  1. Moon, K., Guallar, E., Navas-Acien, A., 2012. Arsenic exposure and cardiovascular disease: an updated systematic review. Curr. Atheroscler. Rep. 14 (6), 542-555.
  2. Chen, Y., et al., 2013a. Arsenic exposure from drinking water, arsenic methylation capacity, and carotid intima-media thickness in Bangladesh. Am. J. Epidemiol. 178 (3), 372-381.
  3. Hsieh, Y.C., et al., 2008. Risk of carotid atherosclerosis associated with genetic polymor- phisms of apolipoprotein E and inflammatory genes among arsenic exposed residents in Taiwan. Toxicol. Appl. Pharmacol. 227 (1), 1-7.
  4. Hsieh, Y.C., et al., 2011. Significantly increased risk of carotid atherosclerosis with arsenic exposure and polymorphisms in arsenic metabolism genes. Environ. Res. 111 (6), 804-810.
  5. Wang, Y.H., et al., 2007. Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P1 on the risk of carotid atherosclerosis in Taiwan. Atherosclerosis 192 (2), 305-312.
  6. Wu, M.M., et al., 2010. GT-repeat polymorphism in the heme oxygenase-1 gene promoter and the risk of carotid atherosclerosis related to arsenic exposure. J. Biomed. Sci. 17, 70.
  7. Hsueh, Y.M., et al., 2005. Genetic polymorphisms of oxidative and antioxidant enzymes and arsenic-related hypertension. J. Toxicol. Environ. Health A 68 (17-18), 1471-1484.
  8. Styblo, M., et al., 2000. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74 (6), 289-299.
  9. Pierce, B.L., et al., 2012. Genome-wide association study identifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bangladesh. PLoS Genet. 8 (2), e1002522.
  10. Engstrom, K., et al., 2011. Polymorphisms in arsenic(+III oxidation state) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism. Environ. Health Perspect. 119 (2), 182-188.
  11. Porter, K.E., et al., 2010. Association of genetic variation in cystathionine-beta-synthase and arsenic metabolism. Environ. Res. 110 (6), 580-587.
  12. Schlawicke Engstrom, K., et al., 2007. Genetic polymorphisms influencing arsenic metab- olism: evidence from Argentina. Environ. Health Perspect. 115 (4), 599-605.
  13. Steinmaus, C., et al., 2007. Genetic polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic. J. Toxicol. Environ. Health A 70 (2), 159-170.
  14. Lindberg, A.L., et al., 2007. Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms. Environ. Health Perspect. 115 (7), 1081-1086.
  15. Rodrigues, E.G., et al., 2012. GSTO and AS3MT genetic polymorphisms and differences in urinary arsenic concentrations among residents in Bangladesh. Biomarkers 17 (3), 240-247.
  16. Agusa, T., et al., 2010. Genetic polymorphisms in glutathione S-transferase (GST) super- family and arsenic metabolism in residents of the Red River Delta, Vietnam. Toxicol. Appl. Pharmacol. 242 (3), 352-362.
  17. Marnell, L.L., et al., 2003. Polymorphisms in the human monomethylarsonic acid (MMA V) reductase/hGSTO1 gene and changes in urinary arsenic profiles. Chem. Res. Toxicol. 16 (12), 1507-1513.
  18. Yu, L., et al., 2003. Genetic variation in genes associated with arsenic metabolism: gluta- thione S-transferase omega 1-1 and purine nucleoside phosphorylase polymor- phisms in European and indigenous Americans. Environ. Health Perspect. 111 (11), 1421-1427.
  19. Klerk, M., et al., 2002. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288 (16), 2023-2031.
  20. Pezzini, A., et al., 2002. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissec- tion and atherothrombotic stroke. Stroke 33 (3), 664-669.
  21. Roest, M., et al., 2001. Methylenetetrahydrofolate reductase 677 C/T genotype and cardio- vascular disease mortality in postmenopausal women. Am. J. Epidemiol. 153 (7), 673-679.
  22. Olshan, A.F., et al., 2003. Risk of atherosclerosis: interaction of smoking and glutathione S- transferase genes. Epidemiology 14 (3), 321-327.
  23. Li, R., et al., 2001. Interaction of the glutathione S-transferase genes and cigarette smoking on risk of lower extremity arterial disease: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 154 (3), 729-738.
  24. de Waart, F.G., et al., 2001. Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers. Atherosclerosis 158 (1), 227-231.
  25. Wang, X.L., et al., 2002. Glutathione S-transferase mu1 deficiency, cigarette smoking and coronary artery disease. J. Cardiovasc. Risk 9 (1), 25-31.
  26. Kolsch, H., et al., 2007. Association of the glutathione S-transferase omega-1 Ala140Asp polymorphism with cerebrovascular atherosclerosis and plaque-associated interleukin-1 alpha expression. Stroke 38 (10), 2847-2850.
  27. Kolsch, H., et al., 2004. Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke. Neurology 63 (12), 2255-2260.
  28. Simeonova, P.P., Luster, M.I., 2004. Arsenic and atherosclerosis. Toxicol. Appl. Pharmacol. 198 (3), 444-449.
  29. Kumagai, Y., Pi, J., 2004. Molecular basis for arsenic-induced alteration in nitric oxide pro- duction and oxidative stress: implication of endothelial dysfunction. Toxicol. Appl. Pharmacol. 198 (3), 450-457.
  30. Chen, Y., et al., 2007. Association between arsenic exposure from drinking water and plasma levels of soluble cell adhesion molecules. Environ. Health Perspect. 115 (10), 1415-1420.
  31. Wu, F., et al., 2012. Association between arsenic exposure from drinking water and plas- ma levels of cardiovascular markers. Am. J. Epidemiol. 175 (12), 1252-1261.
  32. Karim, M.R., et al., 2013. Increases in oxidized low-density lipoprotein and other inflam- matory and adhesion molecules with a concomitant decrease in high-density lipo- protein in the individuals exposed to arsenic in Bangladesh. Toxicol. Sci. 135 (1), 17-25.
  33. Lin, S., et al., 2002. A novel S-adenosyl-L-methionine: arsenic(III) methyltransferase from rat liver cytosol. J. Biol. Chem. 277 (13), 10795-10803.
  34. Zakharyan, R.A., et al., 2001. Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. Chem. Res. Toxicol. 14 (8), 1051-1057.
  35. Gregus, Z., Nemeti, B., 2002. Purine nucleoside phosphorylase as a cytosolic arsenate re- ductase. Toxicol. Sci. 70 (1), 13-19.
  36. Research Council, National, 1999. Arsenic in drinking water. Subcommittee on Arsenic in Drinking Water. National Research Council, Washington, DC, pp. 229-250.
  37. Schuliga, M., Chouchane, S., Snow, E.T., 2002. Upregulation of glutathione-related genes and enzyme activities in cultured human cells by sublethal concentrations of inor- ganic arsenic. Toxicol. Sci. 70 (2), 183-192.
  38. Wang, T.S., et al., 2001. Arsenite induces oxidative DNA adducts and DNA-protein cross- links in mammalian cells. Free Radic. Biol. Med. 31 (3), 321-330.
  39. Lynn, S., et al., 2000. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ. Res. 86 (5), 514-519.
  40. Lee, M.Y., et al., 2003. Arsenic-induced dysfunction in relaxation of blood vessels. Environ. Health Perspect. 111 (4), 513-517.
  41. Lee, P.C., Ho, I.C., Lee, T.C., 2005. Oxidative stress mediates sodium arsenite-induced ex- pression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells. Toxicol. Sci. 85 (1), 541-550.
  42. Lee, T.C., Ho, I.C., 1995. Modulation of cellular antioxidant defense activities by sodium ar- senite in human fibroblasts. Arch. Toxicol. 69 (7), 498-504.
  43. Das, S., et al., 2005. Implications of oxidative stress and hepatic cytokine (TNF-alpha and IL-6) response in the pathogenesis of hepatic collagenesis in chronic arsenic toxicity. Toxicol. Appl. Pharmacol. 204 (1), 18-26.
  44. Straub, A.C., et al., 2009. Arsenic requires sphingosine-1-phosphate type 1 receptors to in- duce angiogenic genes and endothelial cell remodeling. Am. J. Pathol. 174 (5), 1949-1958.
  45. Lemaire, M., et al., 2011. Exposure to moderate arsenic concentrations increases athero- sclerosis in ApoE-/-mouse model. Toxicol. Sci. 122 (1), 211-221.
  46. Hou, Y.C., et al., 2005. Effects of glutamine on adhesion molecule expression and leuko- cyte transmigration in endothelial cells exposed to arsenic. J. Nutr. Biochem. 16 (11), 700-704.
  47. Ahsan, H., et al., 2006. Health Effects of Arsenic Longitudinal Study (HEALS): description of a multidisciplinary epidemiologic investigation. J. Expo. Sci. Environ. Epidemiol. 16 (2), 191-205.
  48. F. Wu et al. / Toxicology and Applied Pharmacology 276 (2014) 195-203
  49. Nixon, D.E., et al., 1991. Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin. Chem. 37 (9), 1575-1579.
  50. Slot, C., 1965. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand. J. Clin. Lab. Invest. 17 (4), 381-387.
  51. Reuter, W., Davidowski, L., Neubauer, K., 2003. Speciation of Five Arsenic Compounds in Urine by HPLC/ICP-MS. Perkin Elmer Application Notes 2003. Available from: http:// www.perkinelmer.com/PDFs/Downloads/app\_speciationfivearseniccompounds.pdf.
  52. Chen, Y., et al., 2013b. A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. Environ. Health Perspect. 121 (7), 832-838.
  53. Desvarieux, M., et al., 2005. Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 111 (5), 576-582.
  54. O'Leary, D.H., et al., 1999. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collab- orative Research Group. N. Engl. J. Med. 340 (1), 14-22.
  55. Kitamura, A., et al., 2004. Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderly men. Stroke 35 (12), 2788-2794.
  56. Touboul, P.J., et al., 2012. Mannheim carotid intima-media thickness and plaque consen- sus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Confer- ences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc. Dis. 34 (4), 290-296.
  57. Lee, P.H., Shatkay, H., 2008. F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res. 36 (Database issue), D820-D824.
  58. Bermejo, J.L., Hemminki, K., 2007. Gene-environment studies: any advantage over envi- ronmental studies? Carcinogenesis 28 (7), 1526-1532.
  59. Le Marchand, L., Wilkens, L.R., 2008. Design considerations for genomic association stud- ies: importance of gene-environment interactions. Cancer Epidemiol. Biomarkers Prev. 17 (2), 263-267.
  60. Chen, Y., et al., 2011a. Arsenic exposure from drinking water and mortality from cardio- vascular disease in Bangladesh: prospective cohort study. BMJ 342, d2431.
  61. Chen, Y., et al., 2011b. Association between arsenic exposure from drinking water and proteinuria: results from the Health Effects of Arsenic Longitudinal Study. Int. J. Epidemiol. 40 (3), 828-835.
  62. Benjamini, Y., Hochberg, Y., 1995. Controlling the false discovery rate -a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 57 (1), 289-300.
  63. Chambless, L.E., et al., 1997. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communi- ties (ARIC) Study, 1987-1993. Am. J. Epidemiol. 146 (6), 483-494.
  64. Agusa, T., et al., 2011. Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms. Int. J. Mol. Sci. 12 (4), 2351-2382.
  65. Hernandez, A., et al., 2008. Role of the Met(287)Thr polymorphism in the AS3MT gene on the metabolic arsenic profile. Mutat. Res. 637 (1-2), 80-92.
  66. Zondervan, K.T., Cardon, L.R., 2004. The complex interplay among factors that influence allelic association. Nat. Rev. Genet. 5 (2), 89-100.
  67. Tseng, C.H., et al., 1997. Lipid profile and peripheral vascular disease in arseniasis- hyperendemic villages in Taiwan. Angiology 48 (4), 321-335.
  68. Hsueh, Y.M., et al., 1998. Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure. Atherosclerosis 141 (2), 249-257.
  69. F. Wu et al. / Toxicology and Applied Pharmacology 276 (2014) 195-203